San Francisco-based medical industry giant McKesson Corp. will bring at least 975 jobs and $157 million in investment to North Texas as it consolidations operations into a new regional office in Irving.
Gov. Greg Abbott made the announcement today and said the Texas Enterprise Fund (TEF) made a grant offer of $9.75 million to McKesson. The company, currently ranked 11th on the list of Fortune 500 companies, distributes pharmaceuticals and medical products. It is buying a 525,000 square foot office building, formerly owned by NEC Corp. of America, at State Highway 114 in Las Colinas .
The city of Irving and the Greater Irving-Las Colinas Chamber of Commerce partnered with the Office of the Governor to facilitate state and local support for McKesson’s expansion. The city of Irving made about $2 million worth of incentives available to the company for the move.
“The city of Irving is thrilled the McKesson Corporation has chosen Irving as its new regional home. We are honored to add another highly-regarded corporate powerhouse to our distinguished and growing list of business partners,” said Irving Mayor Beth Van Duyne. “We are certain McKesson will find Irving to be a dynamic city that provides signature facilities, quality of life amenities and a deep and sophisticated pool of employee talent.”
As part of the plan, McKesson will move 900 workers already in the area to the new location, but also plans to create at least another 975 jobs.
“McKesson’s selection of our community (as part of a five-state search) for its regional headquarters marks one of North Texas region’s single-largest corporate commitments in 2016, as well as Irving’s largest real estate deal in the last decade,” said Beth Bowman, president and CEO of the Greater Irving-Las Colinas Chamber of Commerce in a statement. “McKesson will immediately become one of Irving’s largest employers, bringing an estimated $4.7 Billion in total economic activity over the next decade, while continuing the incredible momentum that Irving-Las Colinas has experienced during the past two years.”
The Irving facility will be in addition to McKesson’s specialty pharmaceutical business that is headquarter in The Woodlands.